• Apicidin as a Histone Deacetylase Inhibitor: Mechanistic Ins

  2026-07-17

  Explore Apicidin, a selective histone deacetylase inhibitor, as both a research tool and emerging mycotoxin. This article delivers advanced mechanistic analysis, translational consequences, and practical assay parameters, offering a unique perspective beyond established workflows.

• Doxycycline Hyclate: Matrix Metalloproteinases Inhibitor in

  2026-07-17

  Doxycycline hyclate enables targeted inhibition of MMP-2 and MMP-9, preserving blood-brain barrier integrity in neurotoxicological models. Its high solubility, validated in vivo efficacy, and robust protocol flexibility make it a premier APExBIO tool for dissecting MMP-driven pathology and optimizing translational workflows.

• EdU Imaging Kits (Cy5): Precision Tools for S-Phase DNA Synt

  2026-07-16

  Discover how EdU Imaging Kits (Cy5) enable highly specific S-phase DNA synthesis measurement, surpassing traditional assays for cell proliferation and genotoxicity studies. This article offers a unique, mechanistic perspective and practical guidance grounded in the latest translational research.

• Streptavidin-FITC: Precision Biotin Detection in IHC and Flo

  2026-07-16

  Streptavidin-FITC from APExBIO empowers researchers to achieve highly specific, reproducible fluorescent detection of biotinylated molecules across immunohistochemistry, flow cytometry, and biotin-streptavidin binding assays. Leveraging the latest insights into sialylation-mediated bacterial adhesion, this article translates bench advances into actionable protocols and troubleshooting strategies for sensitive, multiplexed detection workflows.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome: Cli

  2026-07-15

  This article analyzes a recent case report detailing neuroleptic malignant syndrome (NMS) triggered by prochlorperazine in an elderly patient, highlighting diagnostic challenges when typical laboratory abnormalities are absent. The findings underscore the need for comprehensive clinical assessment and early intervention, with implications for optimizing neuroprotective research models.

• Engineering RNA Nanoparticle Structure via Polyanion Chemist

  2026-07-15

  This study introduces a systematic approach to modulating RNA nanoparticle structure and function by tailoring polyanion chemistry and PEGylation. The findings clarify how molecular design impacts extracellular stability, protein interactions, and transfection efficiency, providing a new framework for high-throughput engineering of RNA delivery systems.

• Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S

  2026-07-14

  Moxidectin, a macrocyclic lactone anthelmintic, targets glutamate-gated chloride channels in parasites and is newly validated as an ergosterol biosynthesis activator in Candida albicans. This dual role underpins both veterinary antiparasitic and emergent antifungal applications, with robust efficacy documented in peer-reviewed and product sources.

• JDJM Modulates Wnt/β-Catenin in KOA Synovium: Mechanistic In

  2026-07-14

  This study demonstrates that Jiawei Duhuo Jisheng mixture (JDJM) downregulates Wnt/β-catenin signaling in synovial fibroblasts and tissue from knee osteoarthritis (KOA) models, with efficacy comparable to direct chemical inhibition. The results offer mechanistic support for targeting Wnt/β-catenin in KOA and inform translational strategies for osteogenic differentiation modulators and fibrotic disease research.

• Caspase 3/7 Drive Autophagy and DNA Repair in Breast Cancer

  2026-07-13

  This study demonstrates that caspase 3 and caspase 7 have a conserved, non-apoptotic role in facilitating cytoprotective autophagy and DNA damage response under non-lethal stress in human breast cancer cells. These insights reshape our understanding of caspase functions in cellular stress adaptation and suggest new avenues for therapeutic targeting of cancer stress responses.

• Açaí Extracts: Cytotoxicity & Enzyme Induction in Human Hepa

  2026-07-13

  This study provides the first systematic evaluation of açaí (Euterpe oleracea) extracts for cytotoxicity and induction of drug-metabolizing enzymes and transporters in human hepatocytes. The findings reveal selective, dose-dependent cytotoxicity for certain extracts but minimal risk of clinically relevant modulation of CYP450s or key transporters, informing safer research and use of botanical supplements.

• Panobinostat (LBH589): Applied Workflows in Cancer Epigeneti

  2026-07-12

  Panobinostat (LBH589) empowers researchers to dissect apoptosis pathways and overcome drug resistance in cancer models through robust, reproducible HDAC inhibition. This article translates bench-proven workflows and troubleshooting strategies into actionable guidance for maximizing assay success and data integrity.

• 3X (DYKDDDDK) Peptide: Precision Tools for Protein Purificat

  2026-07-10

  The 3X (DYKDDDDK) Peptide empowers researchers to achieve ultra-sensitive detection, robust affinity purification, and reliable structural analyses of recombinant proteins—even in complex experimental contexts. Its triple-epitope design and metal-binding versatility streamline workflows and address challenges in immunodetection, crystallography, and ELISA optimization.

• Hierarchical ROS-Responsive Nanoplatforms for Diabetic Perio

  2026-07-09

  This study introduces a hierarchically targeted, ROS-responsive hydrogel-nanoparticle system to disrupt the oxidative stress-inflammation loop in M1 macrophages, central to diabetic periodontitis. The platform demonstrates effective mitochondrial repair, reduced inflammation, and improved bone regeneration, representing a significant advance over conventional periodontitis therapies.

• Hydroxytyrosol: Advanced Antioxidant Strategies in Cardiovas

  2026-07-09

  Explore the multifaceted role of Hydroxytyrosol as a potent antioxidant bioactive compound in cardiovascular health research. This in-depth analysis reveals mechanistic insights, practical assay protocols, and new findings that distinguish Hydroxytyrosol’s application in advanced experimental workflows.

• Difloxacin HCl: Quinolone Antimicrobial Antibiotic in Resear

  2026-07-08

  Difloxacin HCl stands at the crossroads of infectious disease and cancer research, enabling precise antimicrobial susceptibility testing and pioneering multidrug resistance reversal protocols. Its robust solubility profile, high purity, and dual-action mechanism make it indispensable for translational workflows targeting both bacterial pathogens and tumor models.

421 records 9/29 page Previous Next First page 上5页 678910 下5页 Last page